P. Zuck

Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment (2002)

Schürmann, D, Collins, O, Kubin, R, McGivern, J, ...

The objective of the present trial was to compare the efficacy, safety, and tolerability of moxifloxacin (400 mg) given intravenously (i.v.) once daily followed by oral moxifloxacin (400 mg) for 7 to...

Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis (1999)

Langan, C. E., Zuck, P., Vogel, F., McIvor, A., Pierzchala, W., Smakal, M., ...

The efficacy and safety of grepafloxacin were compared with clarithromycin in a randomized, double-blind, multicentre clinical trial of 805 patients with acute bacterial exacerbations of chronic...

A double-blind randomized trial comparing the efficacy and safety of a 5-day course of cefotiam hexetil with that of a 10-day course of penicillin V in adult patients with pharyngitis caused by group A {beta}-haemolytic streptococci (1995)

Carbon, C., Chatelin, A., Bingen, E., Zuck, P., Rio, Y., Guetat, F., ...

A 10-day course of penicillin is the antibiotic regimen currently recommended by the American Heart Association (AHA) as treatment for patients with tonsillitis caused by group A β-haemolytic...

Efficacy and tolerance of cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis (1990)

Periti, P., Novelli, A., Schildwachter, G., Schmidt-Gayk, H., Ryo, Y., Zuck, P.

This European, multicentre trial evaluated the efficacy and tolerance of cefpodoxime proxetil in comparison with co-amoxidav (amoxycillin plus clavulanic acid) in the treatment of acute exacerbations...

Efficacy and tolerance of cefpodoxime proxetil compared with ceftriaxone in vulnerable patients with bronchopneumonia (1990)

Zuck, P., Rio, Y., Ichou, F.

This multicentre, randomized study compared the efficacy and tolerance of cefpodoxime proxetil and ceftriaxone in vulnerable patients with bronchopneumonia. Patients received cefpodoxime proxetil 200...

Note technique (1978)

ZUCK, P.

L'auteur reprend la technique des biopsies pulmonaires transbronchiques réalisées à l'aide d'un fibroscope OLYMPUS SBFB2, sous contrôle d'un amplificateur de brillance. Il insiste surtout sur la...

Intérêt de la biopsie transbronchique perfibroscopique dans le diagnostic des lésions pulmonaires diffuses et localisées (1978)

ZUCK, P., PEIFFER, G., ANTHOINE, D., LAMY, P.

Conclusions : place actuelle et intérêt de la biopsie pulmonaire transbronchique perfibroscopique (1978)

ANTHOINE, D., ZUCK, P., PEIFFER, G., SIMON, B.

Les auteurs rapportent dans cet article les résultats obtenus en France dans 805 cas de biopsies pulmonaires transbronchiques perfibroscopiques. Dans 78 % des cas un fragment de parenchyme...

Randomized Controlled Trial of Sequential Intravenous (i.v.) and Oral Moxifloxacin Compared with Sequential i.v. and Oral Co-Amoxiclav with or without Clarithromycin in Patients with Community-Acquired Pneumonia Requiring Initial Parenteral Treatment

Finch, R., Schürmann, D., Collins, O., Kubin, R., McGivern, J., Bobbaers, H., ...

The objective of the present trial was to compare the efficacy, safety, and tolerability of moxifloxacin (400 mg) given intravenously (i.v.) once daily followed by oral moxifloxacin (400 mg) for 7 to...

Randomized Controlled Trial of Sequential Intravenous (i.v.) and Oral Moxifloxacin Compared with Sequential i.v. and Oral Co-Amoxiclav with or without Clarithromycin in Patients with Community-Acquired Pneumonia Requiring Initial Parenteral Treatment

Finch, R., Schürmann, D., Collins, O., Kubin, R., McGivern, J., Bobbaers, H., ...

The objective of the present trial was to compare the efficacy, safety, and tolerability of moxifloxacin (400 mg) given intravenously (i.v.) once daily followed by oral moxifloxacin (400 mg) for 7 to...